Literature DB >> 11438661

Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.

A Takano1, I Usui, T Haruta, J Kawahara, T Uno, M Iwata, M Kobayashi.   

Abstract

A pathway sensitive to rapamycin, a selective inhibitor of mammalian target of rapamycin (mTOR), down-regulates effects of insulin such as activation of Akt (protein kinase B) via proteasomal degradation of insulin receptor substrate 1 (IRS-1). We report here that the pathway also plays an important role in insulin-induced subcellular redistribution of IRS-1 from the low-density microsomes (LDM) to the cytosol. After prolonged insulin stimulation, inhibition of the redistribution of IRS-1 by rapamycin resulted in increased levels of IRS-1 and the associated phosphatidylinositol (PI) 3-kinase in both the LDM and cytosol, whereas the proteasome inhibitor lactacystin increased the levels only in the cytosol. Since rapamycin but not lactacystin enhances insulin-stimulated 2-deoxyglucose (2-DOG) uptake, IRS-1-associated PI 3-kinase localized at the LDM was suggested to be important in the regulation of glucose transport. The amino acid deprivation attenuated and the amino acid excess enhanced insulin-induced Ser/Thr phosphorylation and subcellular redistribution and degradation of IRS-1 in parallel with the effects on phosphorylation of p70 S6 kinase and 4E-BP1. Accordingly, the amino acid deprivation increased and the amino acid excess decreased insulin-stimulated activation of Akt and 2-DOG uptake. Furthermore, 2-DOG uptake was affected by amino acid availability even when the degradation of IRS-1 was inhibited by lactacystin. We propose that subcellular redistribution of IRS-1, regulated by the mTOR-dependent pathway, facilitates proteasomal degradation of IRS-1, thereby down-regulating Akt, and that the pathway also negatively regulates insulin-stimulated glucose transport, probably through the redistribution of IRS-1. This work identifies a novel function of mTOR that integrates nutritional signals and metabolic signals of insulin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11438661      PMCID: PMC87231          DOI: 10.1128/MCB.21.15.5050-5062.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

Review 1.  Signaling pathways in insulin action: molecular targets of insulin resistance.

Authors:  J E Pessin; A R Saltiel
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes.

Authors:  K Egawa; N Nakashima; P M Sharma; H Maegawa; Y Nagai; A Kashiwagi; R Kikkawa; J M Olefsky
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

3.  G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes.

Authors:  T Imamura; P Vollenweider; K Egawa; M Clodi; K Ishibashi; N Nakashima; S Ugi; J W Adams; J H Brown; J M Olefsky
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

4.  Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibition.

Authors:  A V Lee; J L Gooch; S Oesterreich; R L Guler; D Yee
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1.

Authors:  T Haruta; T Uno; J Kawahara; A Takano; K Egawa; P M Sharma; J M Olefsky; M Kobayashi
Journal:  Mol Endocrinol       Date:  2000-06

6.  Insulin-like growth factor I-mediated degradation of insulin receptor substrate-1 is inhibited by epidermal growth factor in prostate epithelial cells.

Authors:  H Zhang; H Hoff; C Sell
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

7.  CAP defines a second signalling pathway required for insulin-stimulated glucose transport.

Authors:  C A Baumann; V Ribon; M Kanzaki; D C Thurmond; S Mora; S Shigematsu; P E Bickel; J E Pessin; A R Saltiel
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

8.  Expression and function of IRS-1 in insulin signal transmission.

Authors:  X J Sun; M Miralpeix; M G Myers; E M Glasheen; J M Backer; C R Kahn; M F White
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

9.  Activation of mitogen-activated protein kinase and phosphatidylinositol 3'-kinase is not sufficient for the hormonal stimulation of glucose uptake, lipogenesis, or glycogen synthesis in 3T3-L1 adipocytes.

Authors:  R J Wiese; C C Mastick; D F Lazar; A R Saltiel
Journal:  J Biol Chem       Date:  1995-02-17       Impact factor: 5.157

Review 10.  Insulin action and the insulin signaling network.

Authors:  B Cheatham; C R Kahn
Journal:  Endocr Rev       Date:  1995-04       Impact factor: 19.871

View more
  84 in total

1.  Alpha-lipoic acid supplementation reduces mTORC1 signaling in skeletal muscle from high fat fed, obese Zucker rats.

Authors:  Zhuyun Li; Cory M Dungan; Bradley Carrier; Todd C Rideout; David L Williamson
Journal:  Lipids       Date:  2014-11-01       Impact factor: 1.880

2.  GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation.

Authors:  Isao Usui; Takeshi Imamura; Hiroaki Satoh; Jie Huang; Jennie L Babendure; Christopher J Hupfeld; Jerrold M Olefsky
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

Review 3.  Interleukin-6 and insulin sensitivity: friend or foe?

Authors:  A L Carey; M A Febbraio
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

Review 4.  Tailoring mTOR-based therapy: molecular evidence and clinical challenges.

Authors:  Gaetano Santulli; Hana Totary-Jain
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

5.  Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes.

Authors:  T Sasaoka; K Fukui; T Wada; S Murakami; J Kawahara; H Ishihara; M Funaki; T Asano; M Kobayashi
Journal:  Diabetologia       Date:  2005-01-15       Impact factor: 10.122

Review 6.  Signaling by target of rapamycin proteins in cell growth control.

Authors:  Ken Inoki; Hongjiao Ouyang; Yong Li; Kun-Liang Guan
Journal:  Microbiol Mol Biol Rev       Date:  2005-03       Impact factor: 11.056

Review 7.  mTOR is a key modulator of ageing and age-related disease.

Authors:  Simon C Johnson; Peter S Rabinovitch; Matt Kaeberlein
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

8.  S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2.

Authors:  Jin Zhang; Zhanguo Gao; Jun Yin; Michael J Quon; Jianping Ye
Journal:  J Biol Chem       Date:  2008-10-24       Impact factor: 5.157

9.  Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo.

Authors:  Teresa Krakauer; Marilyn Buckley; Haleem J Issaq; Stephen D Fox
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

10.  Chronic Exposure to Proline Causes Aminoacidotoxicity and Impaired Beta-Cell Function: Studies In Vitro.

Authors:  Zhenping Liu; Per B Jeppesen; Søren Gregersen; Lotte Bach Larsen; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2016-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.